This paper describes a protocol for the synthesis of gold nanorods, based on the use of hydroquinone as reducing agent, plus the different mechanisms for controlling their size and aspect ratio.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This paper describes a protocol for the synthesis of gold nanorods, based on the use of hydroquinone as reducing agent, plus the different mechanisms for controlling their size and aspect ratio.
Gold nanorods are an important kind of nanoparticles characterized by peculiar plasmonic properties. Despite their widespread use in nanotechnology, the synthetic methods for the preparation of gold nanorods are still not fully optimized. In this paper we describe a new, highly efficient, two-step protocol based on the use of hydroquinone as a mild reducing agent. Our approach allows the preparation of nanorods with a good control of size and aspect ratio (AR) simply by varying the amount of hexadecyl trimethylammonium bromide (CTAB) and silver ions (Ag+) present in the "growth solution". By using this method, it is possible to markedly reduce the amount of CTAB, an expensive and cytotoxic reagent, necessary to obtain the elongated shape. Gold nanorods with an aspect ratio of about 3 can be obtained in the presence of just 50 mM of CTAB (versus 100 mM used in the standard protocol based on the use of ascorbic acid), while shorter gold nanorods are obtained using a concentration as low as 10 mM.
Gold nanoparticles (AuNPs) are one of the most widespread and promising nanostructures to be used in biomedical applications. Their use is essential in many point-of-care in vitro diagnostics products.1 They have been proposed as an effective tool for a number of other different applications: as a contrast agent in imaging studies,2 as a drug delivery system3 and as drugs for light-induced thermotherapy (or photothermal therapy).4 The great potential of AuNPs has driven, in the last twenty years, intense research on the development of new synthesis that is able to increase the control on the size and shape obtained.....
Access restricted. Please log in or start a trial to view this content.
1. Synthesis of Gold Nanorods
Note: Use highly purified water throughout.
Access restricted. Please log in or start a trial to view this content.
UV visible spectra of the gold seeds can be seen in Figure 1. UV visible spectra acquired at different times after the injection of the gold seeds are presented in Figure 2. UV visible spectra and transmission electron microscopic (TEM) images of the obtained gold nanorods are shown in Figure 3. UV visible spectra and transmission electron microscopic (TEM) images of gold nanorods with different aspect ratio obtained by varying the amount.......
Access restricted. Please log in or start a trial to view this content.
The protocol presented here applies hydroquinone, an aromatic molecule characterized by a weak reduction potential, to produce gold nanorods. There are two main advantages of the present protocol toward the most commonly employed synthetic route based on the use of ascorbic acid: the first is that hydroquinone is able to almost quantitatively reduce the gold ions allowing the production of higher amount of gold nanorods.11 The latter is given by the fact that it requires a lower amount of CTAB and a subsequent.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
Funding for this research was provided by the Italian Ministry of Health under the frame of EuroNanoMed II (European Innovative Research & Technological Development Projects in Nanomedicine, project title: ''InNaSERSS'').
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Gold(III) chloride trihydrate | Sigma Aldrich | 520918 | |
| Hydroquinone | Sigma Aldrich | H17902 | |
| Silver Nitrate | Sigma Aldrich | 209139 | toxic |
| Sodium Borohydride | Sigma Aldrich | 480886 | |
| Hexadecyltrimethylammonium bromide (CTAB) | Sigma Aldrich | H5882 | Acute Tox. (oral). In this study we tested three different batches of CTAB (H5882) from Sigma Aldrich. Two of them were marked as made in China while one as made in India. In our experience only the batches marked as made in China were effective for the preparation of AuNR. |
| Spectrophotometer | Thermo scientific | Nanodrop 2000C | |
| TEM | JEOL | 2100 |
Access restricted. Please log in or start a trial to view this content.